Revenue ($USD) : $572,041,908
Revenue (foreign currencies) : ¥75,200,000,000
R&D spend : not available
Employees : not available
Fiscal year end : 12/31/22
CEO : Toshihiko Kai, president and CEO; Masaru Yamamura, medical division GM

Nikkiso holds over half the dialysis machine market in Japan and has a significant global presence. The company has diversified into blood purification devices, equipment for surgery, perioperative, and emergency care, and offers artificial pancreas technology for clinical use. –CN